logo
logo
Sign in

E-cigarettes and products designed to reduce nicotine dependence are expected to drive growth in the Smoking Cessation and Nicotine De-Addiction Products Market.

avatar
Shivani
E-cigarettes and products designed to reduce nicotine dependence are expected to drive growth in the Smoking Cessation and Nicotine De-Addiction Products Market.

Tobacco cessation, often known as Smoking Cessation and Nicotine De-addiction Products, entails quitting smoking. Tobacco contains nicotine, a neurotransmitter that induces addiction by releasing glutamate, dopamine, and gamma-aminobutyric acid (GABA). Smoking cessation products are more effective in treating cigarette and tobacco addiction. Nicotine replacement therapy (NRT), electronic cigarettes, and therapeutic medications such as anti-depressants and nicotine receptor agonists are all part of the global market for Smoking Cessation and Nicotine De-addiction Products.


Because of its damaging effects on the cardiovascular and pulmonary systems, the government is prioritising strong laws to manage nicotine and cigarette addiction. Smoking prohibition in public places, high tobacco product taxes, and assistance for smoking cessation therapy are all government measures aimed at helping people quit smoking. As a result, during the projected period, the global market for smoking cessation and nicotine de-addiction products is expected to grow at a rapid rate. Some of the market's major players are Johnson & Johnson, Pfizer, GlaxoSmithKline, Takeda Pharmaceuticals, Revolymer PLC, and Cipla. The primary companies in the e-cigarette market are NJOY and VMR products. In the market for smoking cessation and nicotine de-addiction, GlaxoSmithKline and Pfizer are the global leaders.


collect
0
avatar
Shivani
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more